Biomarker Workshop V - From Technologies to Targets and Biomarkers
The Biomarker Workshop held at the NMI has become a fixed date for a growing number of proteomics researchers. The 5th Biomarker Workshop will be held on 4th March 2009 (10.00 - 17.30) at the NMI in Reutlingen.
2009 programme
Biomarkers for psychiatric disorders
Sabine Bahn MD PhD MRC Psych, Project Leader, University of Cambridge, Institute of Biotechnology, Cambridge Centre for Neuropsychiatric Research (CCNR), Tennis Court Road, Cambridge, CB2 1QT, United Kingdom
Biomarker discovery on the widescreen
Prof. Dr. Thomas Herget, Senior Director PC-R-New Technology Evaluation, Performance & Life Science Chemicals, Merck KgaA, Frankfurter Str. 250, 64293 Darmstadt
From arrays towards fighting the tuberculosis epidemic
Dr. Gerd Michel, Senior Technology Officer, FIND - Foundation for Innovative New Diagnostics, 71 avenue Louis Casai, 1216 Cointrin/Geneva, Switzerland
Miniaturized immunoassays – technologies & applications
Thomas Joos PhD, Head Biochemistry Department, NMI Natural and Medical Sciences Institute at the University of Tübingen, Markwiesenstr. 55, 72770 Reutlingen, Germany
Gene networks represent robust transcriptional biomarkers
Thomas Werner, PhD, CEO & CSO, Genomatix Software GmbH, Bayerstrasse 85A, 80335 München, Germany
Quantitative proteomics in biomarker discovery
Dr. Friedrich Lottspeich, Max Planck Institute of Biochemistry, Protein Analytics, Am Klopferspitz, 82152 Martinsried, Germany
Fibrin fragments – biomarker, danger signal and potential therapeutic!
Prof. Dr. Dr. Kai Zacharowski, FRCA, Director of the Hospital of Anaesthesiology, Intensive Medicine and Pain Therapy, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany
Multiplexing for diagnostic applications - specific immunoglobulin analysis for al-lergic and autoimmune diseases
Per Matsson PhD, Chief Technology Officer, Associate Professor, Uppsala University, Phadia AB, P.O. Box 6460, SE-751 37 Uppsala, Sweden
2008 programme
Aptamer-Based Biomarker Discovery and Diagnostics
Dr. Larry Gold, CEO and Chairman of the Board -
SomaLogic, Inc., 1775 38th Street - Boulder, CO 80301, USA
Seeing is Treating - Molecular Imaging in Diagnosis and Therapy. A Step Towards Personalized Medicine
Oliver Steinbach, PhD, Department Head Bio-Molecular Engineering, PHILIPS Research Laboratories, Eindhoven, The Netherlands
Miniaturized and Parallelized Immunoassays
Dr. Thomas Joos, Head Biochemistry Department, NMI Natural and Medical Sciences Institute at the University of Tübingen, 72770 Reutlingen, Germany
Protein Microarrays: Technologies – Patents – Market Perspectives
Dr. Hans Berger, HB Consulting, Eckertstr. 111, 8020 Graz, Austria
Biomarker and Stem Cells
C. Thomas Caskey, M.D., F.A.C.P. Executive V.P. of Molecular Medicine and Genetics, The University of Texas, 1825 Pressler St., Suite 205, Houston, TX 77030, USA
Biomarker Discovery Using Multianalyte Profiling
Mike Spain, M.D. Chief Medical Officer, Rules Based Medicine, Duval Road, Austin, TX 78759, USA
From Proteomics Biomarker Discovery to Validation Using Multiplex Protein Assays - An Update
Dr. Hanno Langen, Roche Center for Medical Genomics, F. Hoffmann-La Roche, Basel, Switzerland
Triple X Proteomics – A Perspective for Immunoaffinity Mass Spectrometry
Oliver Poetz, PhD, Senior Scientist, NMI Natural and Medical Sciences Institute at the University Tübingen, Reutlingen, Germany
On 31st January 2007, scientists from industrial and academic research gathered at the NMI in Reutlingen, Germany, to take part in the 3rd Biomarker Workshop and discuss the latest progress, applications and trends in the field of proteomics and biomarkers. The 3rd Biomarker Workshop was once again such a huge success that there is no doubt that the series of biomarker workshops will be continued in 2008.
Speakers and PDF files of the 2007 lectures for download
Dr. Thomas Joos,
NMI Natural and Medical Sciences Institute
Protein microarrays: technologies and applications (download PDF file)
Prof. Steven H. Y. Wong, PhD
Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA
Pharmacogenomics and pharmacoproteomics enabling personalized medicine for drug addiction and toxicology (download PDF file)
Dr. Thomas Werner
Genomatix Software GmbH, Munich, Germany
Genomics and proteomics meet in regulatory networks: perspectives for systems biology (download PDF file)
Dr. Jan van Oostrum
Genome & Proteome Sciences, Novartis Institutes for Biomedical Research, Basel, Switzerland
Linking proteomics to signalling pathways and diseases
(download PDF file)
Prof. Ulf Landegren MD, PhD
Department of Genetics and Pathology/Molecular Medicine, Rudbeck Laboratory, 75185 Uppsala, Sweden
Searching for protein biomarkers in solution and in situ (download PDF file)
Dr. Hanno Langen
Roche Center for Medical Genomics, F. Hoffmann-La Roche, Basel, Switzerland
From proteomics biomarker discovery to validation using multiplex protein assays
Prof. Sophia Hober
Royal Institute of Technology, Stockholm, Schweden
A human protein atlas for normal and cancer tissues
(download PDF file)
Web partners of the event
Future Science Group
GIT Verlag GmbH & Co. KG
Discovery Today
http://www.drugdiscoverytoday.com
Clinical Proteomics
http://www.clinical.proteomics-journal.com